BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10494304)

  • 21. Industry sponsorship in research and publishing: who is really to blame for perceived bias?
    Amsden GW
    Ann Pharmacother; 2004 Apr; 38(4):714-6. PubMed ID: 14982974
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluating solutions to sponsorship bias.
    Doucet M; Sismondo S
    J Med Ethics; 2008 Aug; 34(8):627-30. PubMed ID: 18667655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Difficulties with conducting clinical trials in France].
    Zannad F; Plétan Y
    Therapie; 2001; 56(4):341-7. PubMed ID: 11677850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of industry sponsorship to published outcomes in gastrointestinal clinical research.
    Brown A; Kraft D; Schmitz SM; Sharpless V; Martin C; Shah R; Shaheen NJ
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1445-51. PubMed ID: 17101295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethical dilemmas encountered during clinical drug trials.
    Daicos GK
    Hum Health Care; 2001; 1(2):E9. PubMed ID: 14986633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical trials in Norway--completion and reporting are not satisfactory].
    Sandaker L; Fjeld B; Reikvam A; Lislevand H; Madsen S
    Tidsskr Nor Laegeforen; 2004 Nov; 124(22):2888-90. PubMed ID: 15550958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Physicians and drug industry: attitudes and practice].
    Aasland OG; Førde R
    Tidsskr Nor Laegeforen; 2004 Oct; 124(20):2603-6. PubMed ID: 15534631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Managing physician financial conflicts of interest in clinical trials conducted in the private practice setting.
    Williams KM
    Food Drug Law J; 2004; 59(1):45-77. PubMed ID: 15190925
    [No Abstract]   [Full Text] [Related]  

  • 29. Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? Results from a questionnaire survey.
    Rutledge P; Crookes D; McKinstry B; Maxwell SR
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):663-7. PubMed ID: 14762982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug costs: research and development costs: the great illusion.
    Prescrire Int; 2004 Feb; 13(69):32-6. PubMed ID: 15055226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [No bluff to be discovered in clinical trials].
    Berglund T
    Lakartidningen; 2009 Mar 25-31; 106(13):952-3. PubMed ID: 19441200
    [No Abstract]   [Full Text] [Related]  

  • 32. Small study on industry trial sponsorship leads to big questions about quality and bias.
    Twombly R
    J Natl Cancer Inst; 2007 Jul; 99(13):988-90. PubMed ID: 17596566
    [No Abstract]   [Full Text] [Related]  

  • 33. Industry-sponsored research.
    Okike K; Kocher MS; Mehlman CT; Bhandari M
    Injury; 2008 Jun; 39(6):666-80. PubMed ID: 18508054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [ACCOMPLISH and the risks with company sponsored clinical trials].
    Furberg C
    Lakartidningen; 2009 Feb 11-17; 106(7):450. PubMed ID: 19350775
    [No Abstract]   [Full Text] [Related]  

  • 35. Scientific data from clinical trials: investigators' responsibilities and rights.
    Polk HC; Bowden TA; Rikkers LF; Balch CM; Organ CH; Murie JA; Pories WJ; Büchler MW; Neoptolemos JP; Fazio VW; Schwartz SI; Cameron JL; Kelly KA; Grosfeld JL; McFadden DW; Souba WW; Pruitt BA; Johnston KW; Rutherford RB; Arregui ME; Scott-Conner CE; Warshaw AL; Sarr MG; Cuschieri A; McFadyen BV; Tompkins RK
    Br J Surg; 2002 Jun; 89(6):678-9. PubMed ID: 12027976
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical trials: the pitfalls of interpretation.
    Lokhandwalla Y; Dalvi B
    Issues Med Ethics; 1998 Apr; 6(2):47-8. PubMed ID: 15011700
    [No Abstract]   [Full Text] [Related]  

  • 37. Industry, clinical trials, and the cost of cancer drugs: an investor's perspective.
    Fiorino T
    J Clin Oncol; 2007 Jul; 25(19):e21-3. PubMed ID: 17602065
    [No Abstract]   [Full Text] [Related]  

  • 38. Association between pharmaceutical involvement and outcomes in breast cancer clinical trials.
    Peppercorn J; Blood E; Winer E; Partridge A
    Cancer; 2007 Apr; 109(7):1239-46. PubMed ID: 17326054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment by human research ethics committees of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research.
    Newcombe JP; Kerridge IH
    Intern Med J; 2007 Jan; 37(1):12-7. PubMed ID: 17199839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two societies address financial conflicts of interest in gene therapy trials.
    Prof Ethics Rep; 2000; 13(2):6-7. PubMed ID: 11820249
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.